Abstract: A projectile designed to be lead-free and have a ballistic coefficient ranging from about 0.13 to about 0.80 or greater for enhanced energy/performance at extended ranges may have an elongated body formed with a jacket including a wall having an end defining an ogive portion and a cavity or recess defined within the jacket and in which a core is received. The projectile can be configured in various calibers and sizes. The projectile core may be formed from a plurality of core sections, and at least one of the plurality of core sections may include tungsten powder and a lead-free binder material pressed together to form a substantially cylindrical shape or compact. One or more of the core sections further can be sintered, and the one or more core sections may be received in an end-to-end relationship within the cavity defined by the jacket to form a stacked, sectional core.

Abstract: In one embodiment, a navigation system may include at least one self-describing fiducial with a communication element to communicate navigation state estimation aiding information comprising a geographic position of the self-describing fiducial with respect to one or more coordinate systems and a first navigating object to receive navigation information from an exterior system, receive navigation state estimation aiding information from the self-describing fiducial, and compare the navigation information received from the exterior system to the navigation state estimation aiding information to improve navigation parameters of the first navigating object.

Abstract: In one embodiment, a navigation system may include at least one self-describing fiducial with a communication element to communicate navigation state estimation aiding information comprising a geographic position of the self-describing fiducial with respect to one or more coordinate systems and a first navigating object to receive navigation information from an exterior system, receive navigation state estimation aiding information from the self-describing fiducial, and compare the navigation information received from the exterior system to the navigation state estimation aiding information to improve navigation parameters of the first navigating object.

Abstract: A projectile designed to be lead-free and have a ballistic coefficient ranging from about 0.13 to about 0.80 or greater for enhanced energy/performance at extended ranges may have an elongated body formed with a jacket including a wall having an end defining an ogive portion and a cavity or recess defined within the jacket and in which a core is received. The projectile can be configured in various calibers and sizes. The projectile core may be formed from a plurality of core sections, and at least one of the plurality of core sections may include tungsten powder and a lead-free binder material pressed together to form a substantially cylindrical shape or compact. One or more of the core sections further can be sintered, and the one or more core sections may be received in an end-to-end relationship within the cavity defined by the jacket to form a stacked, sectional core.

Abstract: Disclosed herein is a pharmaceutical composition comprising an iron carbohydrate complex for use in a method for treatment or prevention of an iron deficiency of a fetus or an infant, wherein the iron carbohydrate complex is administered to the mother of the fetus or infant.

Abstract: Technology is disclosed for systems, devices, and methods relating to vehicle positioning. A system for vehicle positioning can comprise a passive resonator configured to be embedded in a roadway, and at least one antenna configured to be attached to a vehicle. The at least one antenna can be configured to transmit a first signal to the passive resonator and receive a second signal from the passive resonator at a harmonic frequency of the first signal. Diodes are used to stimulate a resonant circuit to create the second signal. The passive resonator can be configured to receive the first signal from the at least one antenna and transmit a second signal to the at least one antenna. The system can further comprise a processor configured to: calculate a relative position between the vehicle and the passive resonator based on a phase difference observed between the first signal and a reference signal.

Abstract: The present invention relates to pharmaceutical composition comprising an iron carbohydrate complex for use in a method for treatment or prevention of Restless Leg Syndrome (RLS) of a human patient, wherein the human patient prior to treatment has a magnetic resonance phase imaging of 0.02 radians above the average value of a control group in the substantia nigra, thalamus, putamen, or pallidum. The invention provides a higher probability for a RLS patient being treated to experience a relief in symptoms.

Abstract: A projectile designed to be lead-free and have a ballistic coefficient ranging from about 0.13 to about 0.80 or greater for enhanced energy/performance at extended ranges may have an elongated body formed with a jacket including a wall having an end defining an ogive portion and a cavity or recess defined within the jacket and in which a core is received. The projectile can be configured in various calibers and sizes. The projectile core may be formed from a plurality of core sections, and at least one of the plurality of core sections may include tungsten powder and a lead-free binder material pressed together to form a substantially cylindrical shape or compact. One or more of the core sections further can be sintered, and the one or more core sections may be received in an end-to-end relationship within the cavity defined by the jacket to form a stacked, sectional core.

Abstract: The present invention relates to iron complex compounds for therapeutic use which are low in arsenic, chromium, lead, cadmium, mercury and/or aluminum, compositions thereof and processes for preparing said iron complex compounds.

Abstract: The present invention relates to an iron carbohydrate complex for use in a method of increasing the blood haemoglobin concentration in a pregnant non-human mammal, wherein the pregnant non-human mammal having a blood haemoglobin level of 105 g/L or less, is administered one or more doses of iron carbohydrate complex comprising an amount of elemental iron of 1800 mg or more per dose. The method relates to the further effects of decreasing the rate of stillborn offsprings from a pregnant non-human mammal having a blood haemoglobin level of 105 g/L or less, increasing the blood haemoglobin concentration of offspring litters within 3 days from birth and/or weaning, or increasing the litter size in a subsequent parity of a non-human mammal having a blood haemoglobin level of 105 g/L or less.

Abstract: A projectile designed to be lead-free and have a ballistic coefficient ranging from about 0.13 to about 0.80 or greater for enhanced energy/performance at extended ranges may have an elongated body formed with a jacket including a wall having an end defining an ogive portion and a cavity or recess defined within the jacket and in which a core is received. The projectile can be configured in various calibers and sizes. The projectile core may be formed from a plurality of core sections, and at least one of the plurality of core sections may include tungsten powder and a lead-free binder material pressed together to form a substantially cylindrical shape or compact. One or more of the core sections further can be sintered, and the one or more core sections may be received in an end-to-end relationship within the cavity defined by the jacket to form a stacked, sectional core.

Abstract: In one embodiment, a navigation system may include at least one self-describing fiducial with a communication element to communicate navigation state estimation aiding information comprising a geographic position of the self-describing fiducial with respect to one or more coordinate systems and a first navigating object to receive navigation information from an exterior system, receive navigation state estimation aiding information from the self-describing fiducial, and compare the navigation information received from the exterior system to the navigation state estimation aiding information to improve navigation parameters of the first navigating object.

Abstract: The present invention relates to pharmaceutical composition comprising an iron carbohydrate complex for use in a method for treatment or prevention of Restless Leg Syndrome (RLS) of a human patient, wherein the human patient prior to treatment has a magnetic resonance phase imaging of 0.02 radians above the average value of a control group in the substantia nigra, thalamus, putamen, orpallidum. The invention provides a higher probability for a RLS patient being treated to experience a relief in symptoms.

Abstract: The present invention relates to iron complex compounds for therapeutic use which are low in arsenic, chromium, lead, cadmium, mercury and/or aluminum, compositions thereof and processes for preparing said iron complex compounds.

Abstract: Iron carbohydrate complex for treatment of fetal metal deficiency Disclosed herein is a pharmaceutical composition comprising an iron carbohydrate complex for use in a method for treatment or prevention of an iron deficiency of a fetus or an infant, wherein the iron carbohydrate complex is administered to the mother of the fetus or infant.

Abstract: The present invention relates to pharmaceutical composition comprising an iron carbohydrate complex for use in a method for treatment or prevention of Restless Leg Syndrome (RLS) of a human patient, wherein the human patient prior to treatment has a magnetic resonance phase imaging of 0.02 radians above the average value of a control group in the substantia nigra, thalamus, putamen, orpallidum. The invention provides a higher probability for a RLS patient being treated to experience a relief in symptoms.

Abstract: The present invention relates to an iron carbohydrate complex for use in a method of increasing the blood haemoglobin concentration in a pregnant non-human mammal, wherein the pregnant non-human mammal having a blood haemoglobin level of 105 g/L or less, is administered one or more doses of iron carbohydrate complex comprising an amount of elemental iron of 1800 mg or more per dose. The method relates to the further effects of decreasing the rate of stillborn offsprings from a pregnant non-human mammal having a blood haemoglobin level of 105 g/L or less, increasing the blood haemoglobin concentration of offspring litters within 3 days from birth and/or weaning, or increasing the litter size in a subsequent parity of a non-human mammal having a blood haemoglobin level of 105 g/L or less.

Abstract: In one embodiment, a self-describing fiducial includes a communication element that optically communicates navigation-aiding information. The navigation-aiding information may include a position of the self-describing fiducial with respect to one or more coordinate systems and the communication element communicates the navigation-aiding information to one or more navigating objects in the vicinity of the self-describing fiducial. In another embodiment, the communication element is further configured to communicate supplementary information describing a spatial relationship between the self-describing fiducial and the surrounding environment.

Abstract: Iron carbohydrate complex for treatment of fetal metal deficiency Disclosed herein is a pharmaceutical composition comprising an iron carbohydrate complex for use in a method for treatment or prevention of an iron deficiency of a fetus or an infant, wherein the iron carbohydrate complex is administered to the mother of the fetus or infant.

Abstract: In one embodiment, a self-describing fiducial includes a communication element that optically communicates navigation-aiding information. The navigation-aiding information may include a position of the self-describing fiducial with respect to one or more coordinate systems and the communication element communicates the navigation-aiding information to one or more navigating objects in the vicinity of the self-describing fiducial. In another embodiment, the communication element is further configured to communicate supplementary information describing a spatial relationship between the self-describing fiducial and the surrounding environment.